Fen Huang1, Yunlong Li1, Wenhai Yu2, Shenrong Jing1, Jue Wang1, Feiyan Long1, Zhanlong He2, Chenchen Yang1, Yanhong Bi1, Wentao Cao1, Chengbo Liu1, Xiuguo Hua3, Qiuwei Pan4. 1. Medical Faculty, Kunming University of Science and Technology, Kunming, PR China. 2. Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, PR China. 3. Agriculture and Biotechnology, Shanghai Jiaotong University, Shanghai, PR, China. 4. Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Abstract
UNLABELLED: Hepatitis E virus (HEV) represents the main cause of acute hepatitis worldwide. HEV infection in immunocompromised patients involves a high risk for the development of chronic hepatitis. Because HEV is recognized as a zoonotic pathogen, it is currently believed that swine is the primary reservoir. However, this is not sufficient to justify the strikingly high seroprevalence of HEV in both developing and Western countries. Thus, this study aimed to identify new zoonotic sources that bear a high risk of transmission to humans. We collected fecal, blood, and milk samples of cows in a typical rural region of Yunnan Province in southwest China, where mixed farming of domestic animals is a common practice. HEV RNA was quantified by quantitative real-time polymerase chain reaction, and the whole genome was sequenced. HEV infectivity was assessed in rhesus macaques. We found a high prevalence of active HEV infection in cows as determined by viral RNA positivity in fecal samples. Surprisingly, we discovered that HEV is excreted into milk that is produced by infected cows. Phylogenetic analysis revealed that all HEV isolates from cow/milk belong to genotype 4 and subtype 4h. Gavage with HEV-contaminated raw and even pasteurized milk resulted in active infection in rhesus macaques. Importantly, a short period of boiling, but not pasteurization, could completely inactivate HEV. CONCLUSION: Infectious HEV-contaminated cow milk is recognized as a new zoonotic source that bears a high risk of transmission to humans; these results call attention to understanding and establishing proper measurement and control of HEV zoonotic transmission, particularly in the setting of mixed farming of domestic animals. (Hepatology 2016;64:350-359).
UNLABELLED: Hepatitis E virus (HEV) represents the main cause of acute hepatitis worldwide. HEVinfection in immunocompromised patients involves a high risk for the development of chronic hepatitis. Because HEV is recognized as a zoonotic pathogen, it is currently believed that swine is the primary reservoir. However, this is not sufficient to justify the strikingly high seroprevalence of HEV in both developing and Western countries. Thus, this study aimed to identify new zoonotic sources that bear a high risk of transmission to humans. We collected fecal, blood, and milk samples of cows in a typical rural region of Yunnan Province in southwest China, where mixed farming of domestic animals is a common practice. HEV RNA was quantified by quantitative real-time polymerase chain reaction, and the whole genome was sequenced. HEV infectivity was assessed in rhesus macaques. We found a high prevalence of active HEV infection in cows as determined by viral RNA positivity in fecal samples. Surprisingly, we discovered that HEV is excreted into milk that is produced by infected cows. Phylogenetic analysis revealed that all HEV isolates from cow/milk belong to genotype 4 and subtype 4h. Gavage with HEV-contaminated raw and even pasteurized milk resulted in active infection in rhesus macaques. Importantly, a short period of boiling, but not pasteurization, could completely inactivate HEV. CONCLUSION: Infectious HEV-contaminated cow milk is recognized as a new zoonotic source that bears a high risk of transmission to humans; these results call attention to understanding and establishing proper measurement and control of HEV zoonotic transmission, particularly in the setting of mixed farming of domestic animals. (Hepatology 2016;64:350-359).
Authors: Danielle M Yugo; Caitlin M Cossaboom; Connie Lynn Heffron; Yao-Wei Huang; Scott P Kenney; Amelia R Woolums; David J Hurley; Tanja Opriessnig; Linlin Li; Eric Delwart; Isis Kanevsky; Xiang-Jin Meng Journal: J Med Virol Date: 2018-10-31 Impact factor: 2.327
Authors: Lin Wang; Jade L L Teng; Susanna K P Lau; Siddharth Sridhar; Hongwei Fu; Wanyun Gong; Manyu Li; Qieshi Xu; Yunye He; Hui Zhuang; Patrick C Y Woo; Ling Wang Journal: J Virol Date: 2019-03-21 Impact factor: 5.103
Authors: Anna-Lena Sander; Victor Max Corman; Alexander N Lukashev; Jan Felix Drexler Journal: Cold Spring Harb Perspect Med Date: 2018-12-03 Impact factor: 6.915
Authors: Anna Mrzljak; Lorena Jemersic; Vladimir Savic; Ivan Balen; Maja Ilic; Zeljka Jurekovic; Jadranka Pavicic-Saric; Danko Mikulic; Tatjana Vilibic-Cavlek Journal: Pathogens Date: 2021-06-04